B+L completes Technolas acquisition

Article

Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

Bausch + Lomb has completed the acquisition of Technolas Perfect Vision it was announced earlier.

The new collaboration will be known as Bausch + Lomb Technolas and will continue developing and commercializing surgical laser technology for ophthalmology.

B+L purchased all outstanding shares of Technolas in November 2012 to expand the company's product portfolio into cataract and refractive surgery. The companies have been co-promoting the Victus femtosecond laser, which received marketing approval in Europe in late 2011. Technolas is also developing the Supracor for the treatment of presbyopia.

John Barr, executive president of B+L, commented, "Technolas Perfect Vision’s unique laser platforms will enhance our ability to grow the business and augment our new product pipeline with cutting-edge surgical technology. We are pleased to welcome the Technolas Perfect Vision team to Bausch + Lomb and are committed to a seamless transition as we continue to provide physicians with systems, instruments and intraocular lenses that improve patients’ sight worldwide."

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
EURETINA 2025: Boris Stanzel, MD, methotrexate is rocking the European retina landscape
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
© 2025 MJH Life Sciences

All rights reserved.